BERTOLI, ADA
BERTOLI, ADA
A case of Italian HIV-2 infection: a genetic analysis
2011-03-31 Ciccozzi, M; Babakir Mina, M; Cella, E; Bertoli, A; Lo Presti, A; Maniar, J; Perno, Cf; Ciotti, M
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro
2020-02-23 Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART.
2014-08-01 Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M
Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster
2005-06-19 Bertoli, A; Franco, M; Balzarini, J; Johansson, M; Karlsson, A
An HIV Type 2 Case Series in Italy: A Phylogenetic Analysis
2013-05-25 D'Ettorre, G; Lo Presti, A; Gori, C; Cella, E; Bertoli, A; Vullo, V; Perno, Cf; Ciotti, M; Foley, B; Ciccozzi, M
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen
2013-06-22 Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice
2022-07-03 Armenia, D; Forbici, F; Bertoli, A; Berno, G; Malagnino, V; Gagliardini, R; Borghi, V; Gennari, W; Cicalini, S; Buonomini, A; Teti, E; Lanini, S; Latini, A; Sarmati, L; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Ceccherini-Silberstein, F; Santoro, M
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors
2007-10-01 CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
2011-01-01 Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso
2006-11-01 Nadembega, W; Giannella, S; Simpore, J; CECCHERINI SILBERSTEIN, F; Pietra, V; Bertoli, A; Pignatelli, S; Bellocchi, M; Nikiema, J; Cappelli, G; Bere, A; Colizzi, V; Perno, Cf; Musumeci, S
Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy
2012-01-01 Santoro, M; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains
2017-07-12 Fabeni, L; Berno, G; Fokam, J; Bertoli, A; Alteri, C; Gori, C; Forbici, F; Takou, D; Vergori, A; Zaccarelli, M; Maffongelli, G; Borghi, V; Latini, A; Pennica, A; Mastroianni, C; Montella, F; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Santoro, M
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy
2024-01-01 Armenia, D; Carioti, L; Micheli, V; Bon, I; Allice, T; Bonura, C; Bruzzone, B; Bracchitta, F; Cerutti, F; Giammanco, Gm; Stefanelli, F; Addolorata Bonifacio, M; Bertoli, A; Vatteroni, M; Ibba, G; Novazzi, F; Rosaria Lipsi, M; Cuomo, N; Vicenti, I; Ceccherini-Silberstein, F; Bezenchek, A; Saladini, F; Zazzi, M; Santoro, M
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure
2001-01-01 Zaccarelli, M; Cingolani, A; Forbici, F; Rizzo, M; Trotta, M; Bertoli, A; Di Giambenedetto, S; D’Arrigo, R; Baldini, F; Liuzzi, G; Ciancio, B; Bellocchi, M; Murri, R; Girardi, E; Ammassari, A; Ippolito, G; De Luca, A; Antinori, A; Perno, C
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers
2020-01-01 Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; La Rosa, Ky; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini-Silberstein, F; Perno, C-; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V
Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine
2011-12-09 Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment
2022-01-01 Piermatteo, L; Scutari, R; Chirichiello, R; Alkhatib, M; Malagnino, V; Bertoli, A; Iapadre, N; Ciotti, M; Sarmati, L; Andreoni, M; Ceccherini Silberstein, F; Salpini, R; Svicher, V
Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome
2006-01-01 Tozzi, V; Zaccarelli, M; Bonfigli, S; Lorenzini, P; Liuzzi, G; Trotta, M; Forbici, F; Gori, C; Bertoli, A; Bellagamba, R; Narciso, P; Perno, Cf; Antinori, A
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14
2017-01-01 Fabeni, L; Alteri, C; Di Carlo, D; Orchi, N; Carioti, L; Bertoli, A; Gori, C; Forbici, F; Continenza, F; Maffongelli, G; Pinnetti, C; Vergori, A; Mondi, A; Ammassari, A; Borghi, V; Giuliani, M; De Carli, G; Pittalis, S; Grisetti, S; Pennica, A; Mastroianni, C; Montella, F; Cristaudo, A; Mussini, C; Girardi, E; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Perno, C; Santoro, M; Capobianchi, M; Navarra, A; Palummieria, ; Abbate, I; D'Arrigo, R; Fusco, F; Mariano, A; Nicastri, E; Nurra, G; Puro, V; Sampaolesi, A; Sciarrone, M; Scognamiglio, P; Selleri, M; Sias, C; Zaccarelli, M; Di Carlo, A; Giuliani, M; Vullo, V; Falciano, M; Errigo, F; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Buonomini, Ar; Cerva, C; Mastroianni, C; Lichtner, M; Mercurio, V; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child
2016-01-01 Palma, P; Zangari, P; Alteri, C; Tchidjou, H; Manno, E; Liuzzi, G; Perno, Cf; Rossi, P; Bertoli, A; Bernardi, S
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 31-mar-2011 | A case of Italian HIV-2 infection: a genetic analysis | Ciccozzi, M; Babakir Mina, M; Cella, E; Bertoli, A; Lo Presti, A; Maniar, J; Perno, Cf; Ciotti, M | Articolo su rivista | |
| 23-feb-2020 | A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro | Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V | Articolo su rivista | |
| 1-ago-2014 | A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. | Armenia, D; Soulie, C; Di Carlo, D; Fabeni, L; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Sarmati, L; Giuliani, M; Latini, A; Boumis, E; Zaccarelli, M; Bellagamba, R; Andreoni, M; Marcelin, A; Calvez, V; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Santoro, M | Articolo su rivista | |
| 19-giu-2005 | Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster | Bertoli, A; Franco, M; Balzarini, J; Johansson, M; Karlsson, A | Articolo su rivista | |
| 25-mag-2013 | An HIV Type 2 Case Series in Italy: A Phylogenetic Analysis | D'Ettorre, G; Lo Presti, A; Gori, C; Cella, E; Bertoli, A; Vullo, V; Perno, Cf; Ciotti, M; Foley, B; Ciccozzi, M | Articolo su rivista | |
| 22-giu-2013 | Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen | Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V | Articolo su rivista | |
| 3-lug-2022 | Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice | Armenia, D; Forbici, F; Bertoli, A; Berno, G; Malagnino, V; Gagliardini, R; Borghi, V; Gennari, W; Cicalini, S; Buonomini, A; Teti, E; Lanini, S; Latini, A; Sarmati, L; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Ceccherini-Silberstein, F; Santoro, M | Articolo su rivista | |
| 1-ott-2007 | Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors | CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. | Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf | Articolo su rivista | |
| 1-nov-2006 | Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso | Nadembega, W; Giannella, S; Simpore, J; CECCHERINI SILBERSTEIN, F; Pietra, V; Bertoli, A; Pignatelli, S; Bellocchi, M; Nikiema, J; Cappelli, G; Bere, A; Colizzi, V; Perno, Cf; Musumeci, S | Articolo su rivista | |
| 1-gen-2012 | Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy | Santoro, M; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
| 12-lug-2017 | Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains | Fabeni, L; Berno, G; Fokam, J; Bertoli, A; Alteri, C; Gori, C; Forbici, F; Takou, D; Vergori, A; Zaccarelli, M; Maffongelli, G; Borghi, V; Latini, A; Pennica, A; Mastroianni, C; Montella, F; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Santoro, M | Articolo su rivista | |
| 1-gen-2024 | Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy | Armenia, D; Carioti, L; Micheli, V; Bon, I; Allice, T; Bonura, C; Bruzzone, B; Bracchitta, F; Cerutti, F; Giammanco, Gm; Stefanelli, F; Addolorata Bonifacio, M; Bertoli, A; Vatteroni, M; Ibba, G; Novazzi, F; Rosaria Lipsi, M; Cuomo, N; Vicenti, I; Ceccherini-Silberstein, F; Bezenchek, A; Saladini, F; Zazzi, M; Santoro, M | Articolo su rivista | |
| 1-gen-2001 | Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure | Zaccarelli, M; Cingolani, A; Forbici, F; Rizzo, M; Trotta, M; Bertoli, A; Di Giambenedetto, S; D’Arrigo, R; Baldini, F; Liuzzi, G; Ciancio, B; Bellocchi, M; Murri, R; Girardi, E; Ammassari, A; Ippolito, G; De Luca, A; Antinori, A; Perno, C | Intervento a convegno | |
| 1-gen-2020 | Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers | Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; La Rosa, Ky; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini-Silberstein, F; Perno, C-; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V | Articolo su rivista | |
| 9-dic-2011 | Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine | Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V | Articolo su rivista | |
| 1-gen-2022 | Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment | Piermatteo, L; Scutari, R; Chirichiello, R; Alkhatib, M; Malagnino, V; Bertoli, A; Iapadre, N; Ciotti, M; Sarmati, L; Andreoni, M; Ceccherini Silberstein, F; Salpini, R; Svicher, V | Articolo su rivista | |
| 1-gen-2006 | Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome | Tozzi, V; Zaccarelli, M; Bonfigli, S; Lorenzini, P; Liuzzi, G; Trotta, M; Forbici, F; Gori, C; Bertoli, A; Bellagamba, R; Narciso, P; Perno, Cf; Antinori, A | Articolo su rivista | |
| 1-gen-2017 | Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 | Fabeni, L; Alteri, C; Di Carlo, D; Orchi, N; Carioti, L; Bertoli, A; Gori, C; Forbici, F; Continenza, F; Maffongelli, G; Pinnetti, C; Vergori, A; Mondi, A; Ammassari, A; Borghi, V; Giuliani, M; De Carli, G; Pittalis, S; Grisetti, S; Pennica, A; Mastroianni, C; Montella, F; Cristaudo, A; Mussini, C; Girardi, E; Andreoni, M; Antinori, A; Ceccherini-Silberstein, F; Perno, C; Santoro, M; Capobianchi, M; Navarra, A; Palummieria, ; Abbate, I; D'Arrigo, R; Fusco, F; Mariano, A; Nicastri, E; Nurra, G; Puro, V; Sampaolesi, A; Sciarrone, M; Scognamiglio, P; Selleri, M; Sias, C; Zaccarelli, M; Di Carlo, A; Giuliani, M; Vullo, V; Falciano, M; Errigo, F; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Buonomini, Ar; Cerva, C; Mastroianni, C; Lichtner, M; Mercurio, V; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S | Articolo su rivista | |
| 1-gen-2016 | Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child | Palma, P; Zangari, P; Alteri, C; Tchidjou, H; Manno, E; Liuzzi, G; Perno, Cf; Rossi, P; Bertoli, A; Bernardi, S | Articolo su rivista |